-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Challenges in Red Blood Cell Quality Testing

Symposia: Scientific Workshop on Challenges and Novel Technologies in Red Blood Cell Quality Assessment Program: Scientific Workshops
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Artificial intelligence (AI), Translational Research, Assays, Bioinformatics, Blood banking, Emerging technologies, Technology and Procedures, Gene editing, Profiling, Imaging, Machine learning, Omics technologies
Friday, December 6, 2024: 2:10 PM-3:25 PM
Room 3 (San Diego Convention Center)
Moderator:
and Umut Gurkan, PhD, Case Western Reserve University
Disclosures:
Gurkan: Hemex Health Inc: Consultancy, Current Employment, Current equity holder in private company, Current holder of stock options in a privately-held company, Patents & Royalties, Research Funding; BioChip Labs Inc: Consultancy, Current Employment, Current equity holder in private company, Current holder of stock options in a privately-held company, Patents & Royalties, Research Funding; XaTek Inc: Patents & Royalties; DxNow Inc: Patents & Royalties.
In this session, we will bring together a diverse group of experts to discuss the challenges associated with red blood cell quality testing, including, blood bank, clinical, ethical, and societal perspectives.

Umut Gurkan, PhD

Case Western Reserve University, Cleveland, OH

Jose ANTONIO Cancelas, MD

Dana-Farber Cancer Institute, Boston, MA; Department of Internal Medicine, Harvard Medical School, Boston, MA

Jason Acker, MBA PHD

Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, CAN

Vivien Sheehan, MD, PhD

Emory University School of Medicine, Atlanta, GA